Termination of the Lyrica Japan joint promotional agreement
This theme concerns the co-promotion agreement with Pfizer for Lyrica (pregabalin) in Japan, which ended in July 2022. It addresses the termination of a co-promotion agreement covering a specific product and counterparty.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.